Neuronetics' Double Exposure: A Closer Look at TMS Innovation Neuronetics, a NASDAQ listed company developing transcranial magnetic stimulation (TMS) treatments for neurohealth disorders, has been making waves in the biotech sector.
The company's recent announcements – participating in the B.
Riley Mind, Muscle & Vision Summit and presenting at the Clinical TMS Society Annual Meeting – highlight its growing presence in the field of neuropsychiatric innovation.